Krka Logo

Krka

Develops and sells generic prescription, non-prescription, and animal health products globally.

KRKG | LJSE

Overview

Corporate Details

ISIN(s):
SI0031102120
LEI:
549300H9RLRTRTLRUZ73
Country:
Slovenia
Address:
Šmarješka cesta 006, 8501 Novo mesto
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Krka is a leading international generic pharmaceutical company focused on the development, production, marketing, and sale of human and animal health products. With over 70 years of experience, the company's core business is providing high-quality and innovative generic medicines. Its portfolio is composed of three main segments: prescription pharmaceuticals for treating common diseases, non-prescription products for minor illnesses and preventative care, and a range of animal health products. Krka's products are marketed globally, serving patients in more than 70 countries.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-08 08:30
Legal Proceedings Report
Conclusion regarding perindopril litigation
English 1.4 KB
2025-10-08 08:30
Legal Proceedings Report
Odločitev Komisije EU v zadevi perindopril
Slovene 1.4 KB
2025-09-29 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 142.3 KB
2025-09-29 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-29 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 137.5 KB
2025-09-29 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 124.7 KB
2025-09-22 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-22 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 122.2 KB
2025-09-22 08:30
Transaction in Own Shares
Pridobivanje lastnih delnic
Slovene 2.2 KB
2025-09-19 08:30
Board/Management Information
Konstitutivna seja nadzornega sveta Krke, d. d., Novo mesto
Slovene 1.4 KB
2025-09-19 08:30
Board/Management Information
Constitutive session of the Supervisory Board of Krka, d. d., Novo mesto
English 1.4 KB
2025-09-15 08:30
Transaction in Own Shares
Detailed report on acquisition of treasury shares
English 133.3 KB
2025-09-15 08:30
Transaction in Own Shares
Acquisition of treasury shares
English 2.2 KB
2025-09-15 08:30
Transaction in Own Shares
Podrobno poročilo o nakupih lastnih delnic
English 130.6 KB

Automate Your Workflow. Get a real-time feed of all Krka filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Krka via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884
KUKJEON PHARMACEUTICAL Co.,Ltd Logo
A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.
South Korea 307750
KWANGDONG PHARMACEUTICAL CO.,LTD Logo
Developing drugs & health goods by integrating oriental and Western medicine.
South Korea 009290
Kyivmedpreparat Logo
A leading pharmaceutical producer of antibacterial, generic, and original medicines in various forms.
Ukraine KMED
KYONGBO PHARMACEUTICAL CO., LTD. Logo
Manufactures APIs and finished drugs, offering global CDMO services from development to production.
South Korea 214390
KYORIN Pharmaceutical Co., Ltd. Logo
Researches, develops, and sells a portfolio of ethical, generic, and OTC medicines.
Japan 4569
Kyowa Kirin Co.,Ltd. Logo
Develops antibody medicines for oncology, nephrology, immunology, and allergy.
Japan 4151
KyungdongPharm Logo
Develops and manufactures Rx/OTC drugs & APIs for cardiology and other chronic conditions.
South Korea 011040
KYUNG NAM PHARM.CO.,LTD. Logo
South Korean maker of OTC medicines, health foods, and cosmetics, known for its Lemona Vitamin C.
South Korea 053950
Labiana S.A. Logo
Pharmaceutical CDMO for animal & human health with its own line of vaccines and generics.
Spain LAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.